Tae Wang Kim

Title: Innovations of Tae Wang Kim

Introduction

Tae Wang Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

One of his latest patents is for triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same. This technology provides triazolopyridin-3-ones or pharmaceutically acceptable salts, along with preparation processes and uses. These compounds exhibit inhibitory activity on VAP-1, making them useful for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH). Another notable patent involves triazolone derivatives or salts and their pharmaceutical compositions. Similar to his previous work, these derivatives also show selective inhibitory activity on VAP-1, indicating their potential in treating NASH.

Career Highlights

Tae Wang Kim is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His role at Yuhan Corporation allows him to further his research and development efforts in the pharmaceutical sector. His innovative work has positioned him as a key figure in the industry.

Collaborations

Tae Wang Kim collaborates with several talented individuals, including Tae Dong Han and Hee Jae Tak. These collaborations enhance the research and development process, leading to more effective and innovative solutions in the pharmaceutical field.

Conclusion

Tae Wang Kim's contributions to pharmaceutical innovations are noteworthy, particularly in the development of compounds for treating nonalcoholic hepatosteatosis. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.